Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management: Key Ketone Monitoring Updates and Highlights from the ADA 2025 Conference [Podcast].

IF 3 3区医学 Q3 ENDOCRINOLOGY & METABOLISM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pub Date : 2025-07-29 eCollection Date: 2025-01-01 DOI:10.2147/DMSO.S555697

David Kerr

{"title":"Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management: Key Ketone Monitoring Updates and Highlights from the ADA 2025 Conference [Podcast].","authors":"David Kerr","doi":"10.2147/DMSO.S555697","DOIUrl":null,"url":null,"abstract":"<p><p>This article discusses innovations and advancements in diabetic ketoacidosis (DKA) and ketone monitoring technology from the 2025 American Diabetes Association (ADA) conference held from June 20-23, 2025, in Chicago, Illinois. The session, \"Continuous Ketone Monitoring-Innovations and Clinical Applications\" featured four expert presentations from Drs. Ketan Dhatariya, Lori Lafell, Jennifer Sherr, and Richard Bergenstal, each addressing the clinical implications of physiology and the impact of ketosis and DKA on people with diabetes; methods to detect ketones and current approaches to prevent DKA; ketone sensor performance criteria and current study data; and the potential clinical impact of continuous ketone monitoring. The discussion concludes by discussing a poster presented at the ADA which discussed ketone profiles in free-living people with type 1 diabetes using continuous ketone monitoring. The article closes by underscoring the desire by both clinicians and patients for continuous ketone monitoring to become mainstream sooner rather than later.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"2623-2628"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12319150/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S555697","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

This article discusses innovations and advancements in diabetic ketoacidosis (DKA) and ketone monitoring technology from the 2025 American Diabetes Association (ADA) conference held from June 20-23, 2025, in Chicago, Illinois. The session, "Continuous Ketone Monitoring-Innovations and Clinical Applications" featured four expert presentations from Drs. Ketan Dhatariya, Lori Lafell, Jennifer Sherr, and Richard Bergenstal, each addressing the clinical implications of physiology and the impact of ketosis and DKA on people with diabetes; methods to detect ketones and current approaches to prevent DKA; ketone sensor performance criteria and current study data; and the potential clinical impact of continuous ketone monitoring. The discussion concludes by discussing a poster presented at the ADA which discussed ketone profiles in free-living people with type 1 diabetes using continuous ketone monitoring. The article closes by underscoring the desire by both clinicians and patients for continuous ketone monitoring to become mainstream sooner rather than later.

查看原文本刊更多论文

整合酮和葡萄糖监测优化糖尿病管理：ADA 2025会议的关键酮监测更新和亮点。

本文讨论了2025年6月20日至23日在伊利诺伊州芝加哥举行的2025年美国糖尿病协会（ADA）会议上糖尿病酮症酸中毒（DKA）和酮监测技术的创新和进展。会议主题为“持续酮监测——创新与临床应用”，重点介绍了四位专家。Ketan Dhatariya, Lori Lafell， Jennifer Sherr和Richard Bergenstal，分别发表了生理学的临床意义以及酮症和DKA对糖尿病患者的影响；酮类检测方法及目前预防DKA的方法；酮类传感器性能标准和目前的研究数据；以及持续酮监测的潜在临床影响。讨论最后讨论了在ADA上展示的一张海报，该海报讨论了使用连续酮监测自由生活的1型糖尿病患者的酮谱。文章最后强调，临床医生和患者都希望持续的酮监测早日成为主流。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

5.90

自引率

6.10%

发文量

431

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.